Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Patient Narratives

Routine blood test reveals silent danger of gestational diabetes in high-risk pregnancy

A routine check in the seventh month uncovered dangerously high blood sugar levels in a high-risk pregnant woman, highlighting the importance of screening for gestational diabetes that often shows few or no symptoms but poses serious risks to mother and…

  • apxadmin
  • August 29, 2026
  • News & Research

Silent threat: why routine screening for gestational diabetes is crucial in pregnancy

Gestational diabetes often presents no obvious symptoms, making routine screening vital to prevent risks for mother and baby. Experts highlight how early detection through standard testing can ensure better outcomes for both. Gestational diabetes can arrive quietly in pregnancy, which…

  • apxadmin
  • August 29, 2026
  • Glycaemic Index

Small study suggests time-restricted eating may improve blood sugar control in adults with type 1 diabetes

A recent six-month trial from the University of Illinois Chicago indicates that limiting eating to an eight-hour window could help adults with type 1 diabetes and obesity manage blood sugar levels more effectively without immediate safety concerns, though further research…

  • apxadmin
  • August 29, 2026
  • Glycaemic Index

Unintentional weight loss as a key early sign of diabetes, experts warn

Sudden, unexplained weight loss accompanied by thirst and fatigue may signal the onset of diabetes. Health authorities emphasise the importance of early recognition to prevent serious complications. Sudden, unintentional weight loss can be a warning sign of diabetes, particularly when…

  • apxadmin
  • August 29, 2026
  • Carbohydrate Counting

Institutional investors surge into DexCom amid FDA approval of over-the-counter glucose sensor for children

Fresh filings reveal several institutional investors, including Man Group, are building new positions in DexCom as the FDA broadens access to its Stelo glucose sensor for children, intensifying competition in the growing continuous glucose monitoring sector. DexCom is drawing renewed…

  • apxadmin
  • August 29, 2026
  • Patient Narratives

University of Florida brings Type 1 diabetes screening directly to students in on-campus initiative

The University of Florida Diabetes Institute launches an on-campus screening event at the Plaza of the Americas, aiming to detect Type 1 diabetes early among students and complement ongoing education and support efforts. The University of Florida Diabetes Institute has…

  • apxadmin
  • August 29, 2026
  • News & Research

University of Florida’s innovative screening initiative accelerates early detection of type 1 diabetes

The University of Florida Diabetes Institute launched a campus-based screening event and broader programme to enhance early detection of type 1 diabetes, integrating AI, outreach, and research to prevent serious complications. The University of Florida Diabetes Institute held an on-campus…

  • apxadmin
  • August 29, 2026
  • Treatment & Management

New insights reveal intestine as primary site of metformin’s action in diabetes treatment

A recent study challenges longstanding beliefs by pinpointing the intestine as the main target of metformin’s glucose-lowering effects, offering fresh perspectives on its mechanism and potential for personalised treatment. For decades, metformin has been the first-line medicine for many people…

  • apxadmin
  • August 28, 2026
  • News & Research

Red light therapy shows potential for improving metabolic health, but scientific consensus remains cautious

Emerging research suggests that red and near-infrared light therapy could aid glucose control and reduce insulin resistance, but experts emphasise that further studies are essential before widespread clinical adoption. Red light therapy is being promoted as more than a recovery…

  • apxadmin
  • August 28, 2026
  • Treatment & Management

Type 2 diabetes linked to accelerated brain cortex thinning in older adults

A recent study reveals that type 2 diabetes may contribute to faster thinning of the brain’s cortex in older adults without cognitive impairment, raising concerns about its broader neurological impacts beyond traditional health risks. Type 2 diabetes may be doing…

  • apxadmin
  • August 28, 2026
Prev
1 … 20 21 22 23 24 25 26 … 83
Next

Search

No results

Posts

Diabetes educators call for tailored training to optimise Medtronic’s MiniMed 780G adoption

September 7, 2026

FDA approves tirzepatide (Mounjaro) for cardiovascular risk reduction in high-risk type 2 diabetes patients

August 31, 2026

Safety risks grow as compounded GLP-1 weight-loss drugs expand in unregulated market

August 15, 2026

Global rise in type 1 diabetes forecast to accelerate, with 12.1 million cases by 2049

September 1, 2026

FibroBiologics secures patent for innovative pancreatic islet transplant enhancement

August 11, 2026

Trending now

Brazil’s semaglutide market expands rapidly with new registration ahead of pricing decision
New insights highlight the importance of monitoring added sugar in tea consumption
Folic acid’s potential to reduce diabetes risk in coronary patients faces conflicting evidence
New diabetes foot care guidance emphasises damage prevention over routine bathing

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy